Tim Elliott(@tim_tje) 's Twitter Profileg
Tim Elliott

@tim_tje

Kidani Professor of Immuno-oncology at the University of Oxford. Fellow of Oriel College. Editor in Chief Immunotherapy advances @IMTadvances @britsocimm

ID:494021285

calendar_today16-02-2012 12:49:59

643 Tweets

591 Followers

182 Following

Tim Elliott(@tim_tje) 's Twitter Profile Photo

I support . It widens access to high quality research articles and that’s a good thing. We need to work on a funding model that supports a more diverse authorship.

account_circle
Tim Elliott(@tim_tje) 's Twitter Profile Photo

Today, the new British Society for Immunology journal Discovery Immunology Discovery Immunology Journal has officially presented its first issue: bit.ly/3V1FsrD. As EiC of Immunotherapy Advances Journal, it’s great to see so many high-quality articles from our newest sibling journal – congratulations to all involved!

account_circle
British Society for Immunology(@britsocimm) 's Twitter Profile Photo

💫Huge congratulations from us to the Oxford-AstraZeneca Vaccine Team for being awarded the The Royal Society Copley Medal to recognise their achievement in developing & deploying a vaccine - very well deserved! 👏👏👏

account_circle
Tim Elliott(@tim_tje) 's Twitter Profile Photo

Looking forward to participating in this discussion at Science Museum London this evening. Oxford Cancer sciencemuseum.org.uk/see-and-do/how…

account_circle
Immunotherapy Advances Journal(@IMTadvances) 's Twitter Profile Photo

Read our latest Special Collection led by Dr Adriana Bonomo Fiocruz in English

This collection includes 5 reviews & research articles on engineered as a treatment option for 🎯

read here 🔓bit.ly/3Nh04aJ

Read our latest Special Collection led by Dr Adriana Bonomo @fiocruz_en ⭐ This collection includes 5 reviews & research articles on engineered #Tcells as a treatment option for #cancer 🎯 #OpenAccess read here 🔓bit.ly/3Nh04aJ
account_circle
Immunotherapy Advances Journal(@IMTadvances) 's Twitter Profile Photo

Submit your article to our Special Collection on !

We're interested in:
🔹 Fc engineering
🔹 antibodies
🔹 Drug conjugates
🔹
🔹 Targeted human cytolytic fusion proteins
& more!

Read the ➡bit.ly/3bFknRK

Submit your article to our Special Collection on #AntibodyTherapeutics! We're interested in: 🔹 Fc engineering 🔹 #Bispecific antibodies 🔹 Drug conjugates 🔹 #Immunotoxins 🔹 Targeted human cytolytic fusion proteins & more! Read the #CallForPapers ➡bit.ly/3bFknRK
account_circle
Tim Elliott(@tim_tje) 's Twitter Profile Photo

Lastly, you can also contribute to the growth of Immunotherapy Advances Journal by reading, sharing & citing our articles to help our content reach an even wider audience! academic.oup.com/immunotherapya… 8/8

account_circle
Immunotherapy Advances Journal(@IMTadvances) 's Twitter Profile Photo

play a key role in allergic , releasing into the blood 🩸

Here, Shah et al. Yale Department of Immunobiology review biology, identification & dysregulation to inform development of targeting basophils: bit.ly/3wNouDQ

#Basophils play a key role in allergic #inflammation, releasing #histamine into the blood 🩸 Here, Shah et al. @YaleIBIO review #basophil biology, identification & dysregulation to inform development of #immunotherapies targeting basophils: bit.ly/3wNouDQ
account_circle
Clinical & Experimental Immunology(@CEIjournal) 's Twitter Profile Photo

Direct & indirect engagement of function by antibodies developed for 🎯

In this review, Diana Corogeanu & Sandra Diebold highlight the crucial role of DCs in effective anti-tumour immunity induction: bit.ly/3IUd0R6

Direct & indirect engagement of #DendriticCell function by antibodies developed for #cancer #immunotherapy 🎯 In this review, Diana Corogeanu & Sandra Diebold highlight the crucial role of DCs in effective anti-tumour immunity induction: bit.ly/3IUd0R6
account_circle